Hepatitis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
New gene therapy study results reported from University of Sherbrooke
July 9th, 2007
Current study results from the report, "Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme," have been published. "The development of gene-inactivation systems is an active and important field for both functional genomics and gene therapy. Towards this end, ribozymes (i.e," scientists in Quebec, Canada report. "RNA enzymes), that specifically recognize and subsequently catalyze the cleavage of other target RNA molecules, are attractive molecular tools. Ribozymes represent an interesting alternative to the RNA interference (RNAi) approach for gene inactivation, especially given the fact that RNAi seems to trigger an...
Source: Hepatitis Weekly (2007-07-09)
|
